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Introduction
Methyl-CpG-binding protein-2, MeCP2, was originally identified by its ability to bind methylated DNA (1, 2) . Mutations in the MECP2 gene were later identified to be the cause of Rett syndrome (RTT) (3) . At that time, MeCP2 was thought to be encoded by only three exons; however, an upstream non-coding first exon and a putative promoter were subsequently identified (4) . The translation start site for this transcript (now termed MECP2_E2) in the second of the four exons, and exon 1 and most of exon 2 are within the 5' untranslated region (UTR).
However, in a splice variant of MECP2, termed MECP2_E1, exon 2 is spliced out and translation is initiated from a start codon in exon 1, thus resulting in a slightly larger protein (by 12 amino acids) with a different N-terminal end (5, 6) . The remainder of the protein is identical in the two isoforms, and both contain the methyl-CpG-binding domain (MBD) and transcriptional repressor domain (TRD) (7) . The MeCP2_E2 isoform has been the most widely studied, and in humans, it has 486 residues and a molecular mass of ~53 kDa. However, MeCP2_E1 is slightly larger with 498 amino acids. Studies suggest that the mRNA expression of MECP2_E1 is higher in brain regions than that of MECP2_ E2 (5, 6) and that the former is the predominant isoform in the brain, except for in the thalamus (8) .
Overall, the N-terminal domain (NTD) of MeCP2 (Fig. 1A ) is uncharacterized and intrinsically disordered (9) but is highly conserved across all vertebrate groups and is identical among many higher mammalian species (10) . Interestingly, among the non-mammalian vertebrate groups, only the MeCP2_E1 isoform has been identified thus far, suggesting that this isoform is the evolutionary precursor ( Fig S1) .
Studies suggest that both isoforms might have strongly overlapping functions but with spatial and temporal differences in the transcript abundance (8, 11) . Complementation studies have shown that the two isoforms are able to substitute for each other and fulfill the same basic functions in the mouse brain (11) . However, while the isoform-specific knockout of Mecp2_e1 in mice recapitulates RTT-like features, the Mecp2_e2-specific knockout does not (12, 13) . The functional role of the N-terminus of either isoform has currently not been identified. The presence of missense mutations in relation to disease is a good indicator of a functional role, and these are frequently useful for developing strategies to elucidate function. However, to date, the only exon 1 missense mutation identified in RTT patients is p.Ala2Val, which has been identified in four RTT girls and one patient diagnosed with intellectual disability (14, 15) (Rettbase entry ID # 6622 and 6622; & J. B. Vincent, unpublished data). This mutation would affect the E1 isoform only, leaving the E2 isoform untouched.
The removal of N-terminal methionine (NM) residues and N-terminal acetylation (NA) are the two most common protein modifications that occur either co-translationally or post-translationally (16) . Methionine aminopeptidase 2 (MetAP) is the enzyme that cleaves the NM.
The NM is the translational product of the start AUG codon, which is typically present only transiently on nascent protein, and its efficient removal is influenced by the penultimate residues.
NM excision (NME) is much more common with smaller penultimate residues (≤ 1.29 Å radius); however, NM can be completely or partially retained if the penultimate amino acid has an intermediate-sized side chain (17) . In ribosomal proteins that retain the NM, the second amino acid typically has a side chain of an intermediate size, and valine is often found at this position (18) . Based on a large-scale proteomic analysis, methionine cleavage is less efficient and less likely when the second position amino acid is valine compared to when the second position is alanine (19) . Overall, 100% NME has been reported in proteins with alanine at the penultimate position, whereas NME is reduced to 50% in proteins with valine at the penultimate position. An analysis of peptides with Val or Thr at the penultimate position has found NM to be less efficiently cleaved than in those with Ala, Cys, Gly, Pro, or Ser in vitro (19) .
The addition of an acetyl group at the N-terminal residue (N-terminal acetylation; NA) usually follows directly from the removal of the NM. Among all acetylated peptides, those with a penultimate alanine are most common. However, NA cannot be definitively predicted based on the presence of Ala or Ser as terminal residues or the primary amino acid sequence (16) . NA may influence the protein stability by preventing N-terminal ubiquitination (20) and may also reflect on the protein localization (21) and function. Conversely, some N-terminal acetylated proteins were found to generate a degradation signal for an ubiquitin protein known as Dao10 (22) .
As the MeCP2_E1 NTD has no known ascribed function, we hypothesize that the p.Ala2Val mutation may therefore promote the retention of the NM and the reduction of NA, leading to either a reduced lifespan and/or the mislocalization of the protein. The resulting reduced bio-availability of MeCP2_E1 in girls with the p.Ala2Val mutation leads to RTT or similar phenotypes. Here, we studied the NME and NA of the two MeCP2 isoforms to understand the fundamental functional differences between them and the Ala2Val mutant MeCP2_E1 to provide a molecular link between the mutation and the disease.
Results

Translocation and chromatin localization of MeCP2 WT and p.Ala2Val protein
To analyze the effect of the p.Ala2Val mutation on the MeCP2-DNA interaction, we expressed C-terminal GFP-fusion protein versions of the full-length MeCP2_E1 WT and mutant in mouse Fig. 1 A and B) .
In vitro co-/ post-translational processing of WT and mutant (p.Ala2Val) MeCP2 protein The NTDs of both MeCP2 isoforms (E1 and E2) and MeCP2_E1-Ala2Val were expressed in HEK293T cells to allow for possible N-terminal in vitro modifications in a mammalian cell system and were subsequently purified ( Fig. S1 A and C) . For WT MeCP2_E1, the mass spectrometry analysis found no peptides with NM, indicating complete NME at the P1 position (first residue). Moreover, acetylation of the first alanine (P'1) after NME was observed ( Fig. 2A) . Additionally, we observed several reads with the excision of the first two, three, four or six residues (i.e., methionine (P1) and one, two, three, or five alanines (P'1 to P'5) and acetylation of the subsequent alanine) ( Fig. 2A ). For MeCP2_E2, however, we found reads in which NM (P1) was retained and acetylated ( Fig. 2B ). For MeCP2_E2, we also found several reads with NME (P1) and acetylation of the penultimate valine (P'1) (Fig. 2B) . Unlike WT MeCP2_E1, in sequencing MeCP2_E1-Ala2Val, we found reads with no NME (P1) but with acetylation of the N-terminal methionine (P1) (Fig. 2C) . Additionally, a read with NME (P1) and acetylation of the penultimate valine (P'1) was also observed (Fig. 2C ). For MeCP2_E1-Ala2Val, we also observed some evidence of NM oxidation. All PTMs reported received Ascores of 1000.
Proteasomal degradation of MeCP2
To study the protein half-lives of MeCP2_E1, E2 and MeCP2_E1-Ala2Val, we conducted cycloheximide (CHX) chase assays. For these assays, SH-SY5Y neuroblastoma cells expressing recombinant WT MeCP2_E1, E2 and MeCP2_E1-Ala2Val GFP fusion protein were used (see Materials and Methods). MeCP2_E2 showed the longest half-life, with protein levels detected even 48 hrs after CHX treatment ( 
Real-time mobility dynamics, degradation rates and half-life of WT and mutant (p.Ala2Val) MeCP2 protein in living cells
To further study the mobility and binding dynamics of the WT and Ala2Val mutant MeCP2 protein, fluorescence recovery after photobleaching (FRAP) assays were performed. Fig.   4A shows the pre-bleach, bleached and post-bleached recovery images. Surprisingly, MeCP2_E1-Ala2Val showed a slower recovery compared to WT. WT MeCP2_E1 begins to show some recovery in the 30 th frame, and an almost complete recovery was observed before the 100 th frame, whereas for Ala2Val, the recovery rate was slower and incomplete by the 100 th frame (Fig. 4A) . The quantitative mean FRAP curves have shown a relatively slower fluorescent recovery of p.Ala2Val compared with that of the WT MeCP2_E1 (Fig. 4B) . To calculate the real-time degradation rates (α) and t-half time, we performed real-time bleach-chase experiments (23, 24) . HEK293T cells expressing full-length MeCP2_E1-WT and Ala2Val were used in these experiments. Bleached and unbleached cells were captured using automated time-lapse imaging for a period of 7 hrs as described in Materials and Methods. The protein degradation rates or removal rates (α) were calculated by considering the slope of the difference between the bleached, Pv(t), and unbleached, P(t) protein fluorescence on a semi-logarithmic plot using a linear regression as follows:
( ( ( ) − ( )) (24). We observed a higher decay rate for the MeCP2_E1-Ala2Val protein compared with that of the WT (Fig. 4 C and D) . For the WT, the numeric values of the protein degradation rate (α (1/h)) and t-half time were 0.014 ± 0.002 and 50.7 ± 3.5, respectively, whereas, for Ala2Val, the numeric values of the protein degradation rate (α (1/h)) and t-half time were 0.038 ± 0.002 and 18.3 ± 0.45, respectively (Fig. 4E ).
Discussion
Both human MetAPs (MetAP1 and MetAP2) preferentially cleave the N-terminal methionine of peptides, which have small penultimate residues (i.e., Gly, Ala, Ser, Cys, Pro, Thr, and Val), but MetAP2 has a two-fold higher cleavage activity than MetAP1 for peptides with
Met-Val and Met-Thr residues at the N-terminus (25) . This finding suggests that different MetAP enzymes may be required for NME of the different MeCP2 isoforms or MeCP2_E1-Ala2Val (i.e., MetAP2 to cleave MeCP2_E1-Ala2Val and the MeCP2_E2 isoform). In addition, reduced NME has been observed in peptides with Val or Thr at the penultimate position compared with that in peptides with Ala, Cys, Gly, Pro, or Ser at the penultimate position (19) .
In our results, we have observed a 100% NME of the MeCP2_E1 peptides, whereas NME for MeCP2_E2 and MeCPE1-Ala2Val was reduced, which was consistent with our predictions based on previous observations (19, 26) . Additionally, for MeCP2_E1, we have also observed evidence of 'chew back' up to and including the first (P'1), second (P'2), third (P'3), and fifth (P'5) alanine residues of the seven-alanine polyalanine stretch after NM (P1 position). This result
shows that in addition to NME, subsequent residues of MeCP2_E1 up to at least P'5 can be cleaved to generate variable N-termini. To the best of our knowledge, the cleavage of the penultimate residues in human proteins has not been reported previously. At this point, we can only speculate that such 'chewed back' species of MeCP2_E1 may generate subpopulations possessing different dynamics and/or stability/ longevity.
N-terminal acetylation of proteins, either with or without NME, is a common modification that involves 80-90% of human proteins (27) (Fig. 1 B-D) . No significant difference in the protein-chromocenter localization was noted, indicating that mislocalization of protein is unlikely to be involved in the etiopathogenesis of p.Ala2Val. Additionally, there were no significant differences in the average number and size of chromocenters in cells transfected with the WT and mutant MeCP2_E1 constructs, which rules out an effect of the mutation on the clustering and overall chromatin organization (33) .
In order to investigate the effect of the p.Ala2Val mutation on MeCP2 degradation or half-life, we conducted CHX chase experiments in which further protein translation is prevented by CHX, and MeCP2 protein degradation was monitored over time (22) . In both the neuronal and non-neuronal cell types tested, both WT E1 and E2 were present even at 48 hrs post-CHX treatment. However, in neuroblastoma cells E1-Ala2Val was completely degraded by 24 hrs in the post-treatment cells (Fig. 3 A and C) .
The bleach-chase assays, which measured the protein removal in live cells due to intracellular degradation and cell growth (23, 24) , showed significantly higher removal/ degradation of MeCP2_E1-Ala2Val compared to that of the WT (Fig. 4 C-E) , corroborating the results of the CHX assays. Since MeCP2_E1-Ala2Val shows normal localization at chromocenters ( Fig. 1 A and B) , the slower FRAP recovery time observed suggests that the equilibrium of chromatin-bound versus unbound MeCP2 has shifted as a result of its higher degradation rate. An optimum supply of correctly folded and modified MeCP2 protein is required for its role in the regulation of gene transcription, and either too little or too much
MeCP2 is known to have pathogenic consequences (34, 35 However, the etiopathological mechanism(s) have never been explained (36) (37) (38) (39) (40) . Thus, the mechanistic information gained for MeCP2_E1 Ala2Val may be applicable to other diseases.
Materials and Methods
Cloning, mutagenesis, cell culture and transfections For the protein isolation, the pellets were resuspended in lysis buffer (50 mM HEPES-KOH, 100 mM KCl, 2 mM EDTA, 0.1% NP40, 10% glycerol, 0.25 mM Na 3 VO 4 , 50 mM β-glycerolphosphate, 1 mM NaF, and 1 mM DTT) in each plate used and incubated on ice for 30 min. The cell debris was spun for 15 min at >14-16000 x g at 4 °C. In total, 10 U DNAses I per ml of lysate (Fermentas) were added. The protein concentrations were quantified using a bicinchoninic acid (BCA) protein assay kit (Pierce TM , Thermo Fisher Scientific, Waltham, MA).
The concentration of the protein in the lysate is typically ~5-10 mg/ml. An aliquot of lysate was also collected for the western blot analysis.
Gel-free affinity purification / immunoprecipitation and trypsin digestion for mass spectrometry
For the gel-free GFP-purification, monovalent matrix agarose Nanobeads GFPTrap ® (ChromoTek, Planegg, Germany) were used according to the manufacturer's instruction but with the following modification (Fig. S2 ). Proteins were eluted 2-3 times with three bead volumes of elution buffer (0.5 M NH 4 OH, pH 11.0-12.0 (Sigma), 0.5 mM EDTA) at 4 °C with end-over-end agitation for 15 mins. The eluates were lyophilized in a centrifugal evaporator. The purified proteins were run on a 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel, followed by western blotting using an anti-GFP antibody (Thermo Fisher Scientific, , Waltham, MA) to analyze the purity and assess the molecular size (Fig. S1 A-B) .
Prior to the mass spectrometry, the protein samples were trypsin-digested by resuspending the protein in 50 mM NH 4 
Mass spectrometry to determine the MeCP2 PTMs
The protein samples were digested overnight at 37 ⁰C with trypsin at a 50:1 protein:enzyme ratio. After desalting the peptide mixtures using C 18 reverse phase columns, the tryptic peptides 
Cell fixation and Confocal Imaging
For the fixed cell imaging, the cells were fixed using 4% paraformaldehyde, followed by two washes with ice-cold phosphate buffer saline (PBS), and the transfected cells were then counter stained with DAPI (4′-6′-diamidino-2-phenylindol). Confocal microscopy was used to study the colocalization of MeCP2 accumulation at chromocenters. Z-stacks were acquired with a frame size of 512 x 512 pixels using the GFP 488 and DAPI 405 channels.
Single cell nuclei identification
The identification of the nuclei of single cells and chromocenters was performed by intensitybased thresholding and the implementation of the Water algorithm (41) . Chromocenters and GFP-fusion protein co-localization images were captured by confocal microscopy (Olympus FV-1200) using a 63×/1.3 NA oil objective at 405 nm diode pumped solid state for DAPI, and 488 nm argon for GFP.
Fluorescence recovery after photobleaching
To study the protein recovery and dynamics in living cells, MeCP2_E1 WT and mutant The time-lapse images of the visible fluorescent protein after bleaching (bleached cell, Pv(t)) and the total fluorescent protein (unbleached cells, P(t)) were recorded for ~7 hrs (a total of 105 frames) with ~4-min intervals.
Data analysis
The Olympus FluoView (FV1200) software was used to captured the cell images and calculate the Pearson's correlation coefficient (PCC) for the co-localization of the chromocenters (DAPI) and recombinant protein (GFP). A MATLAB-based Windows application, easyFRAP (42) , was used to analyze the FRAP data. The descriptive statistical data analysis was calculated using
Microsoft Excel and two-tailed unpaired Student's t-test, and the p-values for statistical significance were calculated using GraphPad TM software online tools. 
